Mark Dittmar
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Immunology top 10%
- interferon and immune responses
Papers in
-
- interferon and immune responses 7
- Invertebrate Immune Response Mechanisms 2
-
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- Sara R. Cherry (15 shared papers)Holly R. Ramage (6 shared papers)D. Schultz (9 shared papers)Minghua Li (6 shared papers)Kellie A. Jurado (3 shared papers)Kanupriya Whig (6 shared papers)Robert E. Anderson (3 shared papers)Jae Seung Lee (4 shared papers)
- Journals
- Cell Reports (4 papers)Investigative Ophthalmology & Visual Science (3 papers)PLoS Pathogens (2 papers)mBio (2 papers)Molecular Cell (1 paper)
- Partner nations
- United StatesSwitzerland
In The Last Decade
Mark Dittmar
19 papers receiving 867 citations
Mark Dittmar's Hit Papers
Peers
Comparison fields: 5 of 68
- Infectious Diseases 359
- Immunology 226
- Ophthalmology 49
- Molecular Biology 197
- Computational Theory and Mathematics 41
Countries citing papers authored by Mark Dittmar
This map shows the geographic impact of Mark Dittmar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Dittmar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Dittmar more than expected).
Fields of papers citing papers by Mark Dittmar
This network shows the impact of papers produced by Mark Dittmar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Dittmar. The network helps show where Mark Dittmar may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Dittmar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 182 | |
| 2 | 2021 | 161 | |
| 3 | Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2 Hit paper breakdown → | 2022 | 157 |
| 4 | 2021 | 89 | |
| 5 | 2007 | 67 | |
| 6 | 2019 | 59 | |
| 7 | 2020 | 52 | |
| 8 | 2003 | 28 | |
| 9 | 2019 | 25 | |
| 10 | 2021 | 18 | |
| 11 | 2022 | 16 | |
| 12 | 2020 | 11 | |
| 13 | 2023 | 10 | |
| 14 | 2024 | 4 | |
| 15 | 2023 | 3 | |
| 16 | 2024 | 3 | |
| 17 | In vivo Protection of Photoreceptors from Light Damage in Rat by 17 ß-estradiol | 2003 | 1 |
| 18 | Capsular Washing to Prevent Posterior Capsular Opacification in a Rabbit Model | 2008 | 1 |
| 19 | 2025 | 1 | |
| 20 | 2026 | 0 |
About Mark Dittmar
Mark Dittmar is a scholar working on Immunology, Infectious Diseases, Public Health, Environmental and Occupational Health, Ophthalmology and Molecular Biology, having authored 20 papers that have together received 888 indexed citations. Recurring topics across this work include interferon and immune responses (7 papers), Mosquito-borne diseases and control (5 papers), Retinal Development and Disorders (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Invertebrate Immune Response Mechanisms (2 papers), Intraocular Surgery and Lenses (1 paper), Advanced Proteomics Techniques and Applications (1 paper) and RNA Research and Splicing (1 paper). The work is most often cited by research in Infectious Diseases (359 citations), Immunology (226 citations), Ophthalmology (49 citations), Molecular Biology (197 citations) and Computational Theory and Mathematics (41 citations). Mark Dittmar has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Sara R. Cherry, Holly R. Ramage, D. Schultz, Minghua Li, Kellie A. Jurado, Kanupriya Whig, Robert E. Anderson, Jae Seung Lee, Kristen W. Lynch and Max Ferretti. Their work appears in journals such as Cell Reports, Investigative Ophthalmology & Visual Science, PLoS Pathogens, mBio and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.